Skip to content

Lifeline TLE 484-02

by Intermedics, Inc. 510(k)

Active United States

510(k) K843394

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK843394 Date24 Sep 1984ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lifeline TLE 484-02 is a Permanent Pacemaker Electrode, designed to facilitate cardiac pacing by delivering electrical impulses to the heart. This device is intended for implantation within the cardiovascular system to regulate abnormal heart rhythms by stimulating the heart muscle when necessary.

This device is supplied as a reusable medical implant and is classified under FDA product code DTB, falling under Class III regulatory requirements. It was cleared through the FDA 510(k) pathway in 1984, with a decision date of September 24, and is intended for use in clinical settings where cardiac pacing is required. The device is not described as MRI-safe or single-use in the available data.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Lifeline TLE 484-02 and how does it function in the body?

    The Lifeline TLE 484-02 is a permanent pacemaker electrode designed to regulate abnormal heart rhythms by delivering controlled electrical impulses to the heart muscle. It is implanted within the cardiovascular system to stimulate the heart when natural electrical signals are insufficient, ensuring consistent and appropriate heartbeating for patients with bradycardia or other pacing-dependent conditions.

  • Is the Lifeline TLE 484-02 intended for single-use or can it be reused after implantation?

    The Lifeline TLE 484-02 is explicitly described as a reusable medical implant, meaning it is intended to remain implanted in the patient long-term. Unlike disposable devices, it is not meant for single-use and is designed for sustained cardiac pacing functionality over an extended period.

  • What regulatory pathway was followed for FDA clearance of this device, and what class does it fall under?

    The Lifeline TLE 484-02 was cleared through the FDA 510(k) pathway under the Traditional review process, with a decision date of September 24, 1984. It is classified under FDA product code DTB and falls under Class III regulatory requirements, indicating it is a higher-risk device requiring strict regulatory oversight due to its role in life-sustaining cardiac pacing.

  • Are there any specific storage instructions or considerations for handling the Lifeline TLE 484-02 before implantation?

    While the provided data does not specify detailed storage instructions, as a reusable implantable device, proper handling and sterilization protocols (e.g., autoclave or ethylene oxide) are critical before implantation to ensure patient safety. Clinicians should follow manufacturer guidelines (Intermedics, Inc.) for sterilization and storage to maintain device integrity and functionality.